HomeTOP STORIESargenx to discontinue phase 3 UplighTED trials of efgartigimod in thyroid eye... argenx to discontinue phase 3 UplighTED trials of efgartigimod in thyroid eye disease; stock drops By rogerjudd December 15, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleBiggest stock movers Monday: IRBT, SNY, and moreNext articleCharlotte prioritizes $3.4M transit marketing blitz over safety after recent stabbings, GOP chair says latest articles Industrial Logistics names Anthony Paula as chief financial officer and treasurer Moderna rallies 12% to set new high At 92, the Bard of Bollywood Is Still Writing About Love It’s Raining Boxes: Amazon Drones Overwhelm a Texas Suburb At 92, the Bard of Bollywood Is Still Writing About Love Julie Orringer Didn’t Know How Close to Home Her Novel Would Be explore more Industrial Logistics names Anthony Paula as chief financial officer and treasurer Moderna rallies 12% to set new high At 92, the Bard of Bollywood Is Still Writing About Love It’s Raining Boxes: Amazon Drones Overwhelm a Texas Suburb At 92, the Bard of Bollywood Is Still Writing About Love Julie Orringer Didn’t Know How Close to Home Her Novel Would Be
